Skip to main content

An innovative topical drug delivery system for improving chronic wound healing

Project description

Chronic wound therapy in a tube will soon promote healing safely, simply and effectively

Chronic wounds represent a significant socioeconomic burden impacting patients and healthcare systems. This burden is likely to increase given a growing proportion of elderly people and an increasing prevalence of lifestyle-related diseases such as cancer and diabetes. Improved treatments are desperately needed to avoid potentially devastating consequences. The Swiss company Stratpharma has developed a range of topical gel-based film-forming wound dressings that are also able to deliver drugs to the wound to promote healing. With EU funding of the StrataGRT project, the team is enhancing their proprietary formulation for application to chronic wounds. The project will enable product finalisation as well as scaling up of manufacturing processes and a comprehensive business plan to get it to patients quickly.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

STRATPHARMA AG
Net EU contribution
€ 50 000,00
Address
Aeschenvorstadt 57
4051 Basel
Switzerland

See on map

Region
Schweiz/Suisse/Svizzera Nordwestschweiz Basel-Stadt
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 21 429,00